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Abstract: Pain and discomfort related to episiotomy have been reported to interfere with women’s daily activities 
postpartum, such as sitting, walking and lifting the baby. To compare the effects of curcumin and Povidone-iodine 
solutions for episiotomy healing in primiparous women. 120 healthy primiparous women with a vaginal delivery at 
term were evaluated in this double-blind randomized clinical trial. Randomization was done using a table of random 
list numbers. Perineal healing was evaluated by research midwives blinded to random allocation at 24–48 hours and 
10 days postpartum. Pain was assessed via a visual analogue scale and wound healing via the REEDA scale. 
Analysis was done on the intention-to-treat principle. The main outcome measure was the changes in wound healing 
between the two groups as measured by the REEDA Scale. Secondary outcome measures were perineal pain and 
wound healing 24–48 hours and 10 days after delivery. There was a greater decrease in the total scores of the 
REEDA in the curcumin group than in the Povidone-iodine (P < 0.001), however; there weren't significant 
differences between the groups on the VAS scores. The application of curcumin may assist in the episiotomy 
healing process and could be suitable replacement for Povidone-iodine. 
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1. Introduction 
Perineal trauma is a frequent complication to 
vaginal delivery, and more than 90% of primiparous 
women in developing countries sustain episiotomy 
(Morhe et al., 2004). 
Episiotomy's pain and discomfort have been 
related to difficulties in women’s daily activities in 
postpartum, such as sitting, walking and lifting the 
baby. (Albers et al., 1999). Pain related to episiotomy 
is identified to have a negative impact on sexual 
activities in the first year after childbirth (Glazener, 
1997). Midwives and obstetricians increasingly face 
women who wish to have a caesarean section due to 
fear of genital tract injuries or following previous 
childbirth trauma (McCourt et al 2007; Wagner, 
2000). 
Reducing perineal trauma and associated 
morbidity has a high importance for childbearing 
women and health professionals (Homer and Dahlen 
,2007). Some existing treatments for episiotomy 
healing aren’t effective and some may prolong the 
healing processes (Steen et al , 2000). 
Povidone-iodine is an antiseptic solution 
that is usually used in Iran for episiotomy healing. 
(Vakilian et al., 2011). Tork and Valaei (2002) 
demonstrated that there was no significant difference 
between the Povidone-iodine and water in episiotomy 
wound healing. Cooper et al (1991) even showed that 
Povidone-iodine suppresses function of fibroblasts 
and lymphocytes. 
Alternative and complementary medicine is 
used widely in dermatologic surgery such as 
episiotomy healing. (Reddy et al., 2011). Turmeric is 
considered as the foundation of an herbal 
programmed for health. For thousands of years it has 
been believed to be a key balancing and detoxifying 
herb. The main biologically active part of Turmeric is 
curcumin. Curcuminoids are natural phenols that are 
responsible for the yellow color of turmeric. (Redfern 
R. 2004). Previous research suggested that curcumin 
has anti-inflammatory and pro-wound-healing effects 
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and it exerted its anti-inflammatory effects (Sidhu GS 
et all 1998).by increasing the mRNA transcripts of 
growth factor–beta 1 and fibronectin .It is notice 
worthy that only few number of randomiezed 
controlled trials have been conducted in humans to 
demonstrate its effective properties (White and 
Judkins, 2011; Reddy et al., 2011). 
Therefore, this study was performed to 
compare the effects of curcumin and Povidone-iodine 
solutions for episiotomy healing in primiparous 
women. 
 
2. Material and Methods  
The prospective, parallel randomized 
clinical trial was conducted with recruitment through 
2009 -2010 in the Alzahra Teaching Hospital in 
Tabriz, Iran. The study protocol was approved by the 
Ethics Committee and research center of the Tabriz 
University of Medical Sciences. (14.89.9 No). The 
trial was registered at the Iranian Registry of Clinical 
Trials at www.irct.ir (IRCT138810193027N1). 
Eligibility and recruitment 
Eligible subjects were primiparous women, 
without any acute and chronic disease or allergy, and 
had a healthy pregnancy and delivery after 37 weeks 
of gestation. The women also had to be able to read 
and speak in native language. Exclusion criteria were 
perineal injuries involving the anal sphincter and/or 
anal mucosa, postpartum hemorrhage, previous 
perineal surgery, obvious violence and sexual 
intercourse in the early postpartum period.  
Written informed consent was obtained from 
all women who decided to participate in the study. 
Participants not meeting the eligibility criteria but 
randomized included in the analysis according to the 
intention-to-treat principle. 
Randomization 
In this study, 120 patients participated in 
research project .We prepared 60 Curcumin solution 
as well as 60 Povidone –iodine solution tubes. It is 
notice worthy that all 120 tubes were alike and each 
tube had its specific code. Therefore, researcher and 
patients didn't inform of the content of tubes. 
Participants consumed Curcumin solution 
categorized as an intervention group, participants 
who consumed the Povidone-iodine solution were as 
a control group (60 subjects in each arm). Therefore, 
each patient had a specific tube and she should 
consume it three times a day. It is notice worthy those 
women must wash their hands before using solutions 
in order to reach acceptable results, and every 
necessary information related to consuming solutions 
were explained to each participant individually. 
Scales and Outcome of study  
REEDA scale is as a descriptive scale, it  
can  measure  five components associated with  
healing process ,they are including :Redness ,Edema 
,Ecchymosed, Discharge , Approximation  ,and it is 
graded 0-3 .Therefore ,each category is evaluated and 
a number assigned for a total REEDA score ranging 
from 0-15.In this study ,REEDA scale was applied to 
represent the changes in wound healing among two 
solutions. Consequently, REEDA scores for 
curcumin and Povidone-iodine groups were 2.5 ± 0.8 
and 3.7 ± 1.6 respectively. 
The Visual Analogue Scale (VAS) is a 
subjective measure of pain. It consists of a 10cm line 
with two end-points representing ‘no pain’ and 
‘Unbearable pain'. Patients are asked to rate their pain 
by placing a mark on the line corresponding to their 
current level of pain According to this method, score 
0 (No pain), 1-3 (Mild pain), 4-7(Moderate pain), and 
8-10 (Unbearable pain). Consequently, Pain was 
evaluated by VAS method in our research. 
 
Blinding and compliance 
Both Curcumin and Povidone-iodine 
solutions were packed in similar cans containing a 
code which was known only to the study pharmacist. 
The study was double-blinded and the contents were 
known neither to the participants, nor to the research 
midwives 
 Statistical analysis 
All statistical analyses were done on an 
intention-to-treat basis. Data were entered twice into 
the software SPSS 16 software to correct for typing 
errors. Continuous data with normal distribution were 
analyzed by independent two-sample t-tests and 
without normal distribution by Mann–Whitney U 
test. For categorical variables the Chi-Square and 
Fisher’s exact tests were used. All statistical tests 
were two-tailed, and the significance level was set at 
0.05 ( = 0.05). Values are described as the mean 
(standard deviation) or the median (interquartile 
range) if not normally distributed. 
 
3. Results  
The CONSORT diagram shows the 
participant flowchart through the trial (Figure 1). 
Three women withdrew their consent to participate. 
Thus, the number of intervention and Control group 
were 59 and 58 respectively. 
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Figure 1 Consort diagram of vaginal deliveries in women during study period 
 
Table 1 shows baseline characteristics of the 
curcumin and Povidone-iodine groups. The two 
Groups were comparable and did not differ with 
respect to any of the baseline demographics and 
delivery details variables, indicating successful 
randomization. 
Table 2 represents the comparison of 
episiotomy healing evaluation in the two groups on 
basis of REEDA scale. As shown in table 2, at 24 
hours 8 participants in the curcumin group and 0 of 
the Povidone-iodine group had ecchymosis. Within 
0.25 cm, which was significantly different between 
the groups (P = 0.006). Within 10 days more 
participants in the curcumin group than the Povidone-
iodine group had redness (P = 0.033) and edema (P = 
0.027). The other REEDA parameters were not 
significantly different between the groups.  
According to Table .3, The REEDA scores 
were significantly differed between the both groups 
at 24 hours (P = 0.032) and 10 days (P < 0.001). The 
VAS score differences between the two groups were 
statistically not significant at 24 hours (P = 0. 2) and 
significant in 10 days (P < 0.001); however, 
difference scores between 10th and first day were not 
statically significant. 
 
 
Vaginal deliveries in study period (n = 1820) 
Not meeting inclusion criteria: 
Were multiparous (n= 853) 
Trauma too small or intact perineum (n = 
469) 
Trauma involving anal sphincter (n=100) 
No participation: refusal (n = 278) 
Randomized: 120 
Allocation Curcumin treated: n=60 (50%) 
Received allocated intervention: 58 (97%) 
Did not receive allocated intervention:2 (3%) 
Povidone-iodine treated: n=60 (50%) 
Received allocated intervention: 60 (100%) 
Did not receive allocated intervention:0 (0%) 
Withdrawal of consent (n = 2) 
Interrupted suture (2),  
Lost to follow up: 
24hours: n = 0 
10 days: n = 2 (no 
contact) 
Withdrawal of consent (n = 1) 
Could not read and write in native 
language (1) 
Lost to follow up: 
24 hours: n = 0 
10 days: n = 1 (no 
contact) 
Follow up 
Study sample for intention-to-
treat 
Analysis: n = 58 
Study sample for intention-to-
treat 
Analysis: n = 59 Analyses 
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Table 1 Characteristics of the two groups at baseline 
Variables Curcumin group (N = 59) Povidone - Iodine group (N = 58) P value 
Age (years) 24.2 ± 5.6 22.7 ± 4.0 0.08 
Body mass index (kg/m2) 25.8 ± 3.6 26.1 ± 3.0 0.58 
Gestational age (weeks) 38.1 ± 5.1 38.6 ± 0.8 0.46 
Education (diploma) 28 (47.5) 21 (36.2) 0.35 
Job (housewife) 56 (94.9) 49 (84.5) 0. 61 
Status of operator (supervising midwife) 20 (33.9) 11 (19) 0. 61 
Note: Data are presented as Mean ± SD (standard deviation) and Frequency (Percentage). 
 
Table 2. Comparison of episiotomy healing evaluation in the two groups 
Variables 
Curcumin group (N = 
59) 
Povidone-iodine 
group (N = 58) 
P value 
REEDA Parameters at 24 hours    
Redness    
 None 0 (0) 2 (3.4) 0.244 
 0.25 cm or more 59 (100) 56 (96.6)  
Edema    
 None 6 (10.2) 2 (3.4) 0.272 
 ≤ 1  or more 53 (89.8) 56 (96.6)  
Ecchymosis    
 None 35 (81.4) 37 (100) 0.006 
 0.25 cm or more 8 (18.6) 0 (0)  
Discharge    
 None to serum 53 (89.8) 57 (98.3) 0.114 
 Serosanguinous or bloody 6 (10.2) 1 (1.7)  
Approximation    
 Closed 53 (89.8) 57 (98.3) 0.114 
 Separation <= 3 mm or more 6 (10.2) 1 (1.7)  
    
REEDA Parameters at 10 days    
Redness    
 None 38 (64.4) 26 (44.8) 
0.033 
 0.25 cm or more 21 (35.6) 32 (55.2) 
Edema    
 None 50 (84.7) 39 (67.2) 
0.027 
 ≤ 1 cm 9 (15.3) 19 (32.8) 
Ecchymosis    
 None 58 (98.3) 57 (98.3) 1 
 0.25 cm or more 1 (1.7) 1 (1.7)  
Discharge    
 None to serum 49 (83.1) 45 (77.6) 
0.457 
 Serosanguinous or bloody 10 (16.9) 13 (22.4) 
Approximation    
 Closed 55 (93.2) 49 (84.5) 
0.133 
 Separation <= 3 mm or more 4 (6.8) 9 (15.5) 
Note: Data are presented as Frequency (Percentage). 
 
Table 3 Comparison of the two Groups at 24  hours and 10 days after deliver 
Variables Curcumin group (N=59) 
Povidone-iodine 
group (N=58) 
P value 
VAS score    
 At 24 hours 5 (4,5) 5 (4,5) 0.027 
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 At 10 days 0 (0,0) 1(0,1) < 0.001 
 
Difference scores between 
10th and first day 
-4 (-5,-4) -4 (-5,-4) 0.963 
REEDA score    
 At 24 hours 5 (4,5) 5 (4,5) 0.032 
 At 10 days 0 (0,1) 1 (1,2) < 0.001 
 
Difference scores between 
10th and first day 
-4 (-5,-4) -3 (-3,-2) < 0.001 
Note: Data are presented as Median (Interquartile Range). 
 
A per-protocol analysis was performed to 
investigate whether the noncompliance had 
contributed to validating a false difference between 
the two groups. The per-protocol analysis showed 
statically significant differences in the first outcome 
measure over again (Ps < 0.05, data not shown). 
There were no effects for the curcuminand  
Povidone-iodine groups. 
 
4. Discussions  
The main aim of this study was evaluating 
the role of Curcumin in wound healing in compare to 
Povidone-iodine .Our results showed that the 
curcumin solution for perineal episiotomies was more 
effective way to improvement of wound healing 
processes than the Povidone-iodine. However 
curcumin wasn't effective in pain relief. 
Wound healing is a dynamic, interactive 
process concerning soluble mediators, blood cells, 
extracellular matrix, and parenchymal cells. Wound 
healing has at least three phases -inflammation, 
proliferation, and maturation - which overlap in time. 
(Singer  and Clark , 1999). 
Treatment with curcumin could enhance the 
synthesis of collagen, DNA, fibroblast, vascular 
densities and other important factors in wound 
healing. (Ghasemi Dehkordi et al (2003) 
demonstrated that curcumin pretreatment had a 
helpful effect on the irradiated wound and could be a 
substantial therapeutic strategy for improving 
radiation induced delay in wound repair in cases of 
radiation-induced skin injuries. Also Sidhu et al 
(1999) showed that curcumin accelerate wound 
healing in diabetic rats by increased formation of 
granulation tissue, faster reepithelialization and 
increased collagenization.  
The results of a small clinical trial with 19 
HIV patients found that a liquid soap of curcumin 
could decrease itching symptoms and infectious 
wound and abscess. (Hong et al., 2004).  This study, 
as of first clinical trials conducted in humans showed 
that curcumin solution had wound healing effects.  
Curcumin solution wasn't effective in 
episiotomy pain relief in this study. Vakillian et al 
(2011) also showed that lavender essential oil could 
not cause to decrease of pain. These studies may 
highlight the need for future trials that can employ 
interventions of greater strength of the clinician–
patient relationship because pain relief is never about 
the clinician’s intervention alone. 
Limitations of the present study might be 
related to the absent of control on the nutrition and 
the stresses that may contribute to wound healing and 
pain relief. The authors believe that future trials could 
consider these issues. 
It seems that curcumin can be used as an 
appropriate treatment for postpartum episiotomy 
wound care according to the familiarity of the 
mothers with complementary medicine. 
Consequently, the authors suggest the assessment of 
its application in other areas such as cesarean section 
and umbilical wound healing and also considering the 
use of curcumin solution instead of Povidone-iodine 
for episiotomy wound care. 
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